SOOSAN CEBOTICS(KR:017550)
â‚©1,739.00+39.00 (+2.29%)
KR:017550
SOOSAN CEBOTICS financials statements
â‚©1,739.00
At close:+39.00 (+2.29%)
Want to see KR:017550 full AI Analyst Report?
SOOSAN CEBOTICS (017550) Ratios
SOOSAN CEBOTICS Ratios
KR:017550's free cash flow for Q2 2026 was ₩-1.46B. For the 2026 fiscal year, KR:017550's free cash flow was decreased by ₩-917.02M and operating cash flow was ₩-547.12M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.29 | 2.63 | 1.81 | 1.34 | 1.30 |
| Quick Ratio | 1.11 | 1.28 | 0.96 | 0.59 | 0.65 |
| Cash Ratio | 0.00 | 0.32 | 0.37 | 0.18 | 0.27 |
| Solvency Ratio | 0.32 | 0.28 | 0.25 | 0.17 | 0.14 |
| Operating Cash Flow Ratio | 0.14 | 0.51 | 0.27 | 0.01 | -0.00 |
| Short-Term Operating Cash Flow Coverage | 0.25 | 0.97 | 0.37 | 0.02 | -0.01 |
| Net Current Asset Value | â‚© 76.41B | â‚© 68.08B | â‚© 58.55B | â‚© 32.76B | â‚© 24.24B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.11 | 0.23 | 0.29 | 0.25 |
| Debt-to-Equity Ratio | 0.19 | 0.14 | 0.34 | 0.55 | 0.49 |
| Debt-to-Capital Ratio | 0.16 | 0.13 | 0.26 | 0.36 | 0.33 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.34 | 1.27 | 1.50 | 1.89 | 1.93 |
| Debt Service Coverage Ratio | 0.63 | 0.63 | 0.41 | 0.30 | 0.31 |
| Interest Coverage Ratio | 16.58 | 5.56 | 5.81 | 8.30 | 7.05 |
| Debt to Market Cap | 0.34 | 0.20 | 0.48 | 0.54 | 0.37 |
| Interest Debt Per Share | 613.57 | 463.96 | 1120.83 | 1465.77 | 1137.33 |
| Net Debt to EBITDA | 1.48 | 0.61 | 1.12 | 1.97 | 1.45 |
| Profitability Margins | |||||
| Gross Profit Margin | 22.52% | 24.36% | 23.08% | 22.40% | 19.29% |
| EBIT Margin | 8.29% | 7.51% | 9.95% | 8.03% | 6.40% |
| EBITDA Margin | 10.94% | 10.09% | 12.06% | 9.75% | 8.35% |
| Operating Profit Margin | 8.29% | 6.10% | 8.61% | 7.89% | 5.64% |
| Pretax Profit Margin | 8.13% | 6.41% | 8.47% | 7.08% | 5.60% |
| Net Profit Margin | 6.91% | 4.66% | 7.45% | 5.50% | 4.50% |
| Continuous Operations Profit Margin | 6.91% | 4.66% | 7.45% | 5.50% | 4.50% |
| Net Income Per EBT | 84.89% | 72.73% | 87.95% | 77.71% | 80.38% |
| EBT Per EBIT | 98.15% | 105.12% | 98.36% | 89.68% | 99.31% |
| Return on Assets (ROA) | 5.91% | 3.89% | 6.41% | 6.02% | 4.83% |
| Return on Equity (ROE) | 7.93% | 4.95% | 9.61% | 11.37% | 9.33% |
| Return on Capital Employed (ROCE) | 9.28% | 6.29% | 10.69% | 15.56% | 11.01% |
| Return on Invested Capital (ROIC) | 6.72% | 4.06% | 7.12% | 7.97% | 6.10% |
| Return on Tangible Assets | 6.38% | 4.25% | 6.89% | 6.45% | 5.26% |
| Earnings Yield | 15.42% | 7.82% | 13.95% | 11.42% | 7.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.70 | 6.87 | 9.67 | 8.28 | 7.80 |
| Payables Turnover | 11.88 | 21.42 | 20.36 | 11.80 | 8.97 |
| Inventory Turnover | 2.37 | 2.46 | 2.53 | 2.56 | 2.96 |
| Fixed Asset Turnover | 2.44 | 2.26 | 2.71 | 3.75 | 3.63 |
| Asset Turnover | 0.86 | 0.83 | 0.86 | 1.09 | 1.07 |
| Working Capital Turnover Ratio | 2.95 | 2.84 | 4.32 | 8.04 | 9.55 |
| Cash Conversion Cycle | 177.49 | 184.63 | 163.93 | 155.95 | 129.31 |
| Days of Sales Outstanding | 54.48 | 53.10 | 37.73 | 44.10 | 46.77 |
| Days of Inventory Outstanding | 153.74 | 148.57 | 144.12 | 142.79 | 123.22 |
| Days of Payables Outstanding | 30.73 | 17.04 | 17.92 | 30.94 | 40.68 |
| Operating Cycle | 208.22 | 201.67 | 181.85 | 186.89 | 169.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 138.69 | 372.44 | 378.70 | 29.30 | -8.67 |
| Free Cash Flow Per Share | -30.85 | 230.74 | 136.28 | -162.48 | -166.66 |
| Dividend Paid and CapEx Coverage Ratio | 0.77 | 2.46 | 1.50 | 0.15 | -0.05 |
| Capital Expenditure Coverage Ratio | 0.82 | 2.63 | 1.56 | 0.15 | -0.05 |
| Operating Cash Flow Coverage Ratio | 0.23 | 0.87 | 0.36 | 0.02 | -0.01 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.12 | 0.09 | 0.01 | -0.00 |
| Free Cash Flow Yield | -1.87% | 12.21% | 6.38% | -6.36% | -5.68% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 6.48 | 12.78 | 7.17 | 8.75 | 13.89 |
| Price-to-Sales (P/S) Ratio | 0.45 | 0.60 | 0.53 | 0.48 | 0.63 |
| Price-to-Book (P/B) Ratio | 0.51 | 0.63 | 0.69 | 1.00 | 1.30 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -53.35 | 8.19 | 15.67 | -15.72 | -17.61 |
| Price-to-Operating Cash Flow Ratio | 11.87 | 5.07 | 5.64 | 87.20 | -338.69 |
| Price-to-Earnings Growth (PEG) Ratio | 0.09 | -0.25 | 3.46 | 0.23 | 0.08 |
| Enterprise Value Multiple | 5.57 | 6.52 | 5.55 | 6.91 | 8.95 |
| Enterprise Value | 139.80B | 130.10B | 151.51B | 192.80B | 188.95B |
| EV to EBITDA | 5.57 | 6.52 | 5.55 | 6.91 | 8.95 |
| EV to Sales | 0.61 | 0.66 | 0.67 | 0.67 | 0.75 |
| EV to Free Cash Flow | -72.62 | 9.04 | 19.63 | -21.99 | -21.02 |
| EV to Operating Cash Flow | 16.15 | 5.60 | 7.06 | 121.96 | -404.29 |
| Tangible Book Value Per Share | 2879.81 | 2663.60 | 2774.68 | 2240.73 | 1900.30 |
| Shareholders’ Equity Per Share | 3199.30 | 2984.86 | 3098.81 | 2567.71 | 2263.06 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.15 | 0.27 | 0.12 | 0.22 | 0.20 |
| Revenue Per Share | 3676.15 | 3171.40 | 3999.93 | 5305.90 | 4691.01 |
| Net Income Per Share | 253.85 | 147.85 | 297.92 | 291.88 | 211.25 |
| Tax Burden | 0.85 | 0.73 | 0.88 | 0.78 | 0.80 |
| Interest Burden | 0.98 | 0.85 | 0.85 | 0.88 | 0.87 |
| Research & Development to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
| SG&A to Revenue | 0.07 | 0.08 | 0.12 | 0.07 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.55 | 2.52 | 1.27 | 0.10 | -0.04 |
Currency in KRW

